Fiscal impact reports (FIRs) are prepared by the Legislative Finance Committee (LFC) for standing finance 
committees of the NM Legislature. The LFC does not assume responsibility for the accuracy of these reports 
if they are used for other purposes. 
 
Current FIRs (in HTML & Adobe PDF formats) are a vailable on the NM Legislative Website (legis.state.nm.us).  
Adobe PDF versions include all attachments, whereas HTML versions may not.  Previously issued FIRs and 
attachments may be obtained from the LFC in Suite 101 of the State Capitol Building North. 
 
 
 F I S C A L    I M P A C T    R E P O R T 
 
 
 
SPONSOR  HBIC 
 DATE TYPED  03/07/05  HB  199/HBICS 
 
SHORT TITLE  Amend Optometry Act 
 SB 
  
 
 
  
 ANALYST  McSherry 
 
 APPROPRIATION 
 
 Appropriation Contained  Estimated Additional Impact  Recurring 
or Non-Rec 
 Fund 
Affected 
FY05 
 FY06 
 FY05 
 FY06   
 
 
 
 Minimal Recurring  Optometry 
Board Fund 
(Parenthesis ( ) Indicate Expenditure Decreases) 
 
SOURCES OF INFORMATION 
LFC Files 
Regulations and Licensing Department (RLD) 
Health Policy Commission (HPC) 
Human Services Department (HSD) 
 
SUMMARY 
 
Synopsis of House Business and Industry Substitute Bill 
 
House Business and Industry Committee Substitute for HB199 proposes to amend the Optometry 
Act to increase the scope of optometry by removing restrictions on oral pharmaceuticals, ex-
pands the use of surgical procedures and injections for treatment of the human eye. The effective 
date of the bill is July 1, 2005.
 
 
House Bill 199 amends the Optometry Act by adding language to increase the scope of optome-
try, and removing restrictions on oral pharmaceuticals such as the use of surgical procedures and 
injections for treatment of the human eye.   
 
Specifically, the bill proposes the replacement of specific language restricting surgery or injec-
tions for treatment with specific language describing the surgical and injection procedures which 
would included in the practice of optometry.  The proposed changes would allow laser posterior 
capsulotomy (cataract implants); laser trabeculoplasty (drainage of fluids); laser iridotomy; laser 
iridoplasty; photorefractive keratectomy; and phototherapeutic keratectomy; and minor surgical 
procedures and injections for the correction, relief, treatment or referral of visual defects or ab-
normal conditions of the human eye and its adnexa, including removal of superficial lesions on 
the eyelid and conjunctiva, subcutaneous and sub-conjunctival anesthetic injections and intrale-
sional steroid injections of chalazions and injection to treat anaphylactic reaction.” The substi-